Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China flag China · Delayed Price · Currency is CNY
5.72
-0.04 (-0.69%)
Feb 4, 2026, 12:14 PM CST

SHE:300158 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
290.05584.59800.88720.271,222926.34
Short-Term Investments
-5.01---8.61
Trading Asset Securities
484.61989.621,4482,0194,470-
Cash & Short-Term Investments
774.661,5792,2492,7405,692934.95
Cash Growth
-56.48%-29.78%-17.91%-51.87%508.77%21.88%
Accounts Receivable
991.43718.07856.04809.3945.551,242
Other Receivables
97.7257.7544.7157.44502.5597.62
Receivables
1,089775.81900.75866.741,4481,340
Inventory
660.42775.981,1951,074937.14825.08
Prepaid Expenses
-6.114.180.912.525.26
Other Current Assets
118.3178.49111.08201.62344.11714.47
Total Current Assets
2,6433,2164,4604,8838,4243,819
Property, Plant & Equipment
1,0341,046994.91,0101,047943.39
Long-Term Investments
48.3138.6557.0258.3458.355.87
Goodwill
15.515.540.2440.2440.242,335
Other Intangible Assets
293.17288.85260.07258.39250.37199.5
Long-Term Accounts Receivable
---0.121.112.51
Long-Term Deferred Tax Assets
25.8224.9721.0118.8723.8329.13
Long-Term Deferred Charges
136.56101.37200.37201.06195.49182.76
Other Long-Term Assets
315.59251.29146.680.4153.2135.28
Total Assets
4,5114,9836,1806,55110,0937,603
Accounts Payable
305.51328.01418504.48584.92289.31
Accrued Expenses
33.8229.55251.35289.2410.52593.92
Short-Term Debt
23.0638.110.120.48210.77413.11
Current Portion of Leases
1.782.011.220.310.731.5
Current Income Taxes Payable
51.09--9.33422.710.33
Current Unearned Revenue
56.2851.4268.42147.5986.59108.15
Other Current Liabilities
370.5605.94177.98237.9383.86291.37
Total Current Liabilities
842.021,255917.071,2091,8001,708
Long-Term Debt
-0.180.18-100.1432.78
Long-Term Leases
0.61.091.531.081.08-
Long-Term Unearned Revenue
38.9937.6542.7742.4956.3877.96
Long-Term Deferred Tax Liabilities
0.860.980.3--1.09
Other Long-Term Liabilities
0.1827.5474.5474.7281.3150.48
Total Liabilities
882.651,3221,0361,3282,0391,970
Common Stock
1,0051,0051,0271,0271,0271,027
Additional Paid-In Capital
3,6823,6823,7623,7623,7623,762
Retained Earnings
-886.44-906.81421.76465.743,291856.93
Treasury Stock
-52.04-2.84----
Comprehensive Income & Other
-80.51-79.78-32.71-1.39-1.47-1.89
Total Common Equity
3,6683,6985,1795,2548,0805,645
Minority Interest
-39.36-37.37-34.75-30.86-25.15-11.69
Shareholders' Equity
3,6293,6605,1445,2238,0545,633
Total Liabilities & Equity
4,5114,9836,1806,55110,0937,603
Total Debt
25.4441.393.0321.87312.72447.39
Net Cash (Debt)
749.221,5382,2462,7185,379487.56
Net Cash Growth
-57.85%-31.52%-17.36%-49.48%1003.25%-15.85%
Net Cash Per Share
0.741.502.192.645.240.47
Filing Date Shares Outstanding
992.31,0241,0271,0271,0271,027
Total Common Shares Outstanding
992.31,0241,0271,0271,0271,027
Working Capital
1,8011,9613,5433,6746,6232,112
Book Value Per Share
3.703.615.045.117.865.49
Tangible Book Value
3,3593,3934,8794,9567,7893,110
Tangible Book Value Per Share
3.393.314.754.827.583.03
Buildings
-1,1671,1441,0941,033911.92
Machinery
-864.1832.12824.63783.61700.62
Construction In Progress
-119.444.9824.2119.899.56
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.